EICHORPublic-registry site landscape for NCT04993768, “A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP)”, a Progressive Supranuclear Palsy study sponsored by Transposon Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04993768 (registry record) |
| Study title | A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP) |
| Sponsor | Transposon Therapeutics, Inc. |
| Condition(s) | Progressive Supranuclear Palsy |
| Phase | PHASE2 |
| Listed sites | 14 |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT04993768.
Eichor generates a preliminary site-risk snapshot for NCT04993768 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
